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Abstract
Influenza virus infections result in considerable morbidity and mortality both in the temperate and 
tropical world. Influenza surveillance over multiple years is important to determine the impact and 
epidemiology of influenza and to develop a national vaccine policy, especially in countries 
developing influenza vaccine manufacturing capacity, such as Vietnam. We conducted surveillance 
of influenza and influenza-like illness in Vietnam through the National Influenza Surveillance 
System during 2006–2010. At 15 sentinel sites, the first two patients presenting each weekday 
with influenza-like illness (ILI), defined as fever and cough and/or sore throat with illness onset 
within 3 days, were enrolled and throat specimens were collected and tested for influenza virus 
type and influenza A subtype by RT-PCR. De-identified demographic and provider reported 
subsequent hospitalization information was collected on each patient. Each site also collected 
information on the total number of patients with influenza-like illness evaluated per week. Of 
29,804 enrolled patients presenting with influenza-like illness, 6516 (22%) were influenza 
positive. Of enrolled patients, 2737 (9.3%) were reported as subsequently hospitalized; of the 
2737, 527 (19%) were influenza positive. Across all age groups with ILI, school-aged children had 
the highest percent of influenza infection (29%) and the highest percent of subsequent 
hospitalizations associated with influenza infection (28%). Influenza viruses co-circulated 
throughout most years in Vietnam during 2006–2010 and often reached peak levels multiple times 
during a year, when >20% of tests were influenza positive. Influenza is an important cause of all 
influenza-like illness and provider reported subsequent hospitalization among outpatients in 
Vietnam, especially among school-aged children. These findings may have important implications 
for influenza vaccine policy in Vietnam.
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1. Introduction
Influenza virus infection is associated with considerable morbidity and mortality globally, 
including in Southeast Asian nations like Vietnam [1–5]. Moreover, it has been proposed 
that Southeast Asia may be an important region for the evolution of influenza seasonal 
influenza A (H3N2) virus strains that subsequently spread globally [6,7]. Thus, influenza 
virologic surveillance in Southeast Asia is especially important in detecting virus strains that 
may need to be included in annual influenza vaccine development [6,7]. In countries such as 
Vietnam, national influenza vaccine production capacity is currently being developed, so 
that large scale national vaccination programs may soon become more feasible in the region 
[8]. Epidemiological, virological, and clinical data from influenza surveillance in these 
countries can provide important information for policy makers on the burden of seasonal 
influenza and help develop prevention and control policies throughout the region. A 
preliminary report of the first two years of data collection of influenza surveillance in 
Vietnam’s National Influenza Surveillance System (NISS), from 2006 to 2007, indicated 
that 19% of outpatients tested positive for influenza [9]. This report summarizes five years 
(2006–2010) of influenza surveillance among patients with influenza-like illness (ILI) 
seeking care at outpatient clinics in Vietnam, and describes the burden of influenza virus 
infection among those patients who were reported as subsequently hospitalized.
2. Methods and materials
In 2006, Vietnam initiated national influenza surveillance with assistance from the World 
Health Organization (WHO) and the United States Centers for Disease Control and 
Prevention (CDC) through the creation of the National Influenza Surveillance System 
(NISS), as previously described [9]. NISS consists of a network of sentinel sites located in 
the four major regions of Vietnam. NISS is linked to regional public health laboratories, and 
administered by the National Institute of Hygiene and Epidemiology of the Ministry of 
Health [9] (Fig. 1). Sentinel sites include adult and pediatric outpatient clinics at the central, 
provincial, district hospitals, and the smaller stand-alone or polyclinic levels.
Data collection was officially implemented at seven sentinel sites on January 1, 2006 and 
was expanded to 15 sites by July 2007, to include outpatient clinics at four central hospitals, 
two provincial hospitals, seven district hospitals, and two polyclinics (Fig. 1). Of the original 
15 sites, seven sites were located in the Northern Region, four in the Southern Region, three 
in the Central Coastal, and one in the Central Highland Region. In 2009 and 2010, four 
surveillances sites discontinued data collection due to reduced funding: two central hospitals 
in the Northern Region, one district hospital in the Central Coastal Region, and one 
polyclinic in the Southern Region. Because of the relatively small numbers of patients at the 
Central Coastal and Central Highland Regions, for the purposes of these analyses, the two 
regions have been combined into the Central Regions.
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At each participating surveillance sentinel site, the first two patients presenting to the 
designated outpatient clinic with ILI (defined as a measured temperature ≥38 °C and cough 
and/or sore throat) with onset of illness within 3 days were enrolled, and a throat swab was 
collected and placed into viral transport media. Specimens were stored at each surveillance 
site at 4 °C and sent twice a week to a regional laboratory, where specimens were stored at 
−70 °C until tested for influenza viruses each week. Specimens were tested for influenza A 
and B; influenza A viruses were further subtyped for H1, H3 and H5 by reverse transcription 
polymerase chain reaction (RT-PCR) using primers, probes, and reagents recommended by 
the CDC and the WHO, as previously described [9]. In May 2009, NISS also began testing 
for 2009 pandemic influenza A (H1N1) (2009 H1N1) using CDC recommended primers, 
probes, and techniques [10,11].
Demographic, clinical, and epidemiologic data were collected on every enrolled ILI patient, 
including information on provider reported subsequent clinical disposition; that is, whether 
the patient had a hospital admission – either referred or admission on site. This question did 
not specify either the time period for follow-up on subsequent hospitalization status or if the 
patient was simply referred for admission or actually admitted by the provider. In the 
Vietnamese government’s organized health care system, central hospitals are designed to 
evaluate and treat patients requiring the highest level of medical care and possible inpatient 
service, while provincial hospitals, district hospitals and polyclinics, are designed to treat 
patients requiring progressively less intense medical care (Nguyen H. Tuan, personal 
communication). Laboratory and epidemiologic data collected through NISS were entered 
into a Microsoft Access 2003 database and analyzed. Summary data were reported monthly 
to each site and to the Ministry of Health in Vietnam.
For this report, influenza activity by influenza virus type and influenza A virus subtype was 
determined from the weekly percent of enrolled ILI patients that tested positive among all 
tested. For descriptive purposes, we defined periods of peak influenza activity as the weeks 
where >20% of specimens tested positive for any influenza virus. Chi-square tests of 
proportions were used to assess statistical differences across groups when appropriate. For 
illustrative purposes, local polynomial linear regression was used in Fig. 2 to smooth the 
lines for the percent of influenza positive specimens by virus type and influenza A virus 
subtype. Descriptive analyses were performed using Stata 11 (College Station, TX).
3. Results
3.1. Influenza-like illness and influenza virus infection in Vietnam
During January 1, 2006 through December 31, 2010, 326,752 persons presented for care for 
ILI at outpatient clinics participating in NISS; 29,804 (9.1%) were enrolled and tested for 
influenza. Of enrolled patients, 14,556 (49%) were female and the overall median age was 
12 years (range: 1 month–94 years); 18,306 (61%) were <15 years of age (Table 1). Of 
enrolled patients, 13,728 (46%) patients presented to district hospitals, and 12,991 (44%) 
presented to surveillance sites in the Northern Region.
For the entire study period, 6516 (22%) of enrolled ILI patients tested positive for influenza 
viruses. A similar percentage of males (22%) and females (21%) tested positive for 
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influenza viruses. The percentage of ILI patients that tested positive for influenza viruses 
was similar across the types of medical facilities at which patients presented, including 
central, district, and provincial hospitals, and polyclinics (20–23%), and across regions (21–
23%). School-aged children aged 5–14 years were most likely to test positive for influenza 
viruses (29%), whereas the lowest proportion of influenza viruses were identified in children 
aged <6 months (10%) and persons aged >64 years (13%) (Table 1).
3.2. Subsequent hospitalization and influenza illness
Of ILI patients initially presenting to outpatient clinics in NISS, providers reported that 2737 
(9.3%) were subsequently hospitalized. After adjustment for the type of medical facility 
where a sentinel site was designated, since more patients presented to central or district 
hospitals than provincial hospitals or polyclinics, we estimated that 6.6% of ILI patients who 
presented to outpatient clinics were subsequently hospitalized. Males had a marginally 
higher reported level of subsequent hospitalization than females (9.7% vs. 8.6%). Children 
<6 months of age were reported by providers as subsequently hospitalized more commonly 
than adults 25–64 years of age; 20% of children <6 months of age were reported as 
hospitalized versus 6.7% of adults aged 25–64 years (P < 0.001).
Of ILI patients who presented to outpatient clinics, 527 (19%) were influenza positive; when 
adjusting for the type of presenting medical facility, 21% of reported subsequently admitted 
ILI patients were influenza positive. The highest (28%) proportion of influenza infections 
among reported subsequently hospitalized patients was observed among school-aged 
children (5–14 years), followed by patients >64 years of age (23%), and lowest among 
children <6 months of age (4.8%).
Among enrolled influenza positive patients, there was no statistical difference in the percent 
of reported subsequent hospitalization across age groups (range 7–12%; P = 0.19). Provider 
reported subsequent hospitalization was highest (13%) among patients infected with 
seasonal, non-pandemic influenza A (H1N1) compared to influenza A (H3N2), influenza B, 
and 2009 H1N1 (6.4%, 7.4%, and 7.6%, respectively) (P < 0.001).
Differences were noted across regions with regard to ILI patients with a provider reported 
subsequent hospitalization, and for the proportion of influenza virus infections among 
subsequent hospitalizations. Providers in the Central Regions reported the lowest (2.2) 
percent of patients subsequently hospitalized, but the highest proportion of subsequent 
hospitalizations specifically associated with influenza virus infection (38%) (Table 1).
3.3. Influenza subtype by year, age group, and region
From 2006 to 2010, the annual percent of influenza positive specimens ranged from 18% in 
2007 to 26% in 2009 (Table 2). During most years of surveillance, only one influenza A 
subtype tended to dominate circulation over the other (seasonal influenza A (H1N1) vs. 
H3N2), except in 2009, when influenza A (H3N2) circulated widely prior to the emergence 
and eventual dominance of 2009 H1N1. In 2006 and 2008, seasonal influenza A (H1N1) 
dominated circulation, whereas influenza A (H3N2) circulated only at low levels. On the 
other hand, in 2007 and 2010, influenza A (H3N2) dominated circulation, whereas seasonal 
influenza A (H1N1) circulated at low levels. Influenza B viruses circulated widely every 
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year, regardless of influenza A subtype circulation, with peaks in 2006, 2008, and 2010. 
Testing for 2009 H1N1 began in May 2009; 9.4% of all sampled patients were 2009 H1N1 
positive that year. In 2010, 2009 H1N1 continued to circulate, but at much lower levels, and 
influenza B and influenza A (H3N2) virus dominated circulation, while the seasonal 
influenza A (H1N1) virus was not detected since 2009 (Table 2).
Prior to the emergence of 2009 H1N1, the percent of ILI patients positive for influenza A 
infection (both seasonal A(H1) and A(H3)), was similar across age groups, though patients 
>64 years of age had slightly lower levels of influenza A infection than other age groups. In 
contrast, influenza B virus infection was highest (8.2%) among those <15 years of age, 
while 2009 H1N1 infection was highest (5.0%) among young adults aged 15–24 years.
Across regions, although the proportion influenza positive tests were relatively similar 
overall, there were some regional differences by subtype. When compared to the other 
regions, the Southern region had a slightly lower proportion of influenza A (H1N1) positive 
subtypes, but a slightly higher proportion of influenza B positive strains (Table 2). Also, the 
Northern region had a slightly lower proportion of 2009 H1N1 positive subtypes compared 
to other regions (Table 2).
3.4. Influenza circulation by time, overall and by type and subtype
During 2006–2010, influenza viruses circulated throughout the entire year (Fig. 2). 
Influenza A and B viruses often co-circulated, though peaks in circulation between influenza 
A and B viruses, when they did occur, tended to occur at different times of the year. 
Influenza A viruses accounted for 3547 (62%) of all influenza positive ILI cases, compared 
with 2163 (38%) for influenza B (Table 3). Peaks in influenza A virus circulation often 
occurred during the months of May–October, although peaks in influenza A activity also 
occurred outside of these months (Fig. 2). For example, influenza A (H3N2) exhibited two 
distinct peaks in circulation in 2007, one during February–March and another May–October. 
Of all the seasonal influenza A viruses detected, 76% were detected during the months the 
Southern Hemisphere vaccine is typically available suggesting a seasonality to the 
circulation of influenza A viruses (Table 3). Influenza B viruses also often circulated 
throughout the year. When influenza B viruses did reach peak circulation, these peaks 
occurred during November–March, generally within the months the Northern Hemisphere 
influenza vaccine is typically available (Fig. 2). Of all the influenza B viruses detected, 59% 
were during months the Northern Hemisphere vaccine is available, though this pattern was 
not observed in each region. Only in the Central region were influenza B viruses detected at 
much higher levels in the November–May period, whereas influenza B viruses were detected 
at much more similar levels throughout the year in the Southern region and only 56% were 
detected in the November–May period in the Northern Region (Table 3). Of note, circulation 
of 2009 H1N1 was observed from August to December 2009 and peaked during the week of 
September 20, 2009, when 58% of patients presenting with ILI to sentinel sites tested 
positive for 2009 H1N1.
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4. Discussion
During 2006–2010 in Vietnam, influenza represented an important cause of ILI among 
patients presenting for medical evaluation at outpatient clinics in NISS; 22% of sampled 
outpatients presenting with ILI had laboratory-confirmed influenza virus infection. During 
this period, influenza viruses circulated throughout the year and peaks in influenza activity 
occurred at different periods depending upon influenza virus type or subtype. Influenza virus 
infection was also an important cause of provider reported subsequent hospitalization for all 
ILI patients, but especially among school-aged children. Among all patients with ILI 
presenting to outpatient clinics in the surveillance system nearly 10% were reported as 
subsequently hospitalized; of which, nearly 20% tested positive for influenza. School-aged 
children, 5–14 years old, had the highest percentage of influenza virus infections among all 
age groups. School-aged children also had the highest proportion of influenza infection of 
ILI patients who initially presented to outpatient clinics and were reported by providers as 
subsequently hospitalized.
High influenza attack rates among school-aged children regionally and globally have been 
previously reported [12–14]. That provider reported subsequent hospitalization associated 
with ILI is highest among patients <6 months of age likely reflects the fact that children at 
this age are more susceptible to severe disease, likely because of the absence of pre-existing 
immunity to all types of infections [15] and clinical management of this patient population 
may tend to be more conservative. Nonetheless, the relatively low proportion of influenza 
infections among subsequently hospitalized infants may suggest that other pathogens, such 
as rhinoviruses, respiratory syncytial viruses (RSV), and enteroviruses, may also result in 
severe disease in this age group. For example, during two years of surveillance in Laos, 
enterovirus and rhinovirus infections were more common among those children <5 years of 
age than in older age groups [16]. Influenza virus infection is also often associated with 
more severe outcomes among the elderly [17,18]. Although we did observe high levels of 
subsequent hospitalization associated with influenza infection in patients >64 years of age, 
the overall difference in the proportion of influenza positive infections among subsequently 
hospitalized patients among age groups was not statistically significant. This finding likely 
reflects the fact that NISS enrolls patients from outpatient clinics and is not intended to 
include patients directly admitted to hospitals. It may be likely that the older, medically 
fragile populations >64 years of age may progress to severe infection more quickly than 
other age groups, necessitating early direct admission prior to outpatient evaluation and 
thereby missing the opportunity for enrollment in NISS.
Our findings provide an important contribution to the available literature on influenza 
surveillance and the burden of influenza in the region. In a 2008 review of published 
influenza studies in the region, influenza was reported to account for 11–26% of febrile 
illness and 6–14% of hospitalized cases of pneumonia [4]. The slightly higher (19%) percent 
of influenza infections among ILI patients subsequently hospitalized reported here likely 
reflects NISS’s unique study design, which captures influenza infection among persons 
presenting as outpatients, but is not intended to capture influenza infection among all 
hospitalized patients, as in other studies that have described the burden of influenza [4]. 
During two years of influenza surveillance in Laos, 29.5% of outpatients with ILI and 12.6% 
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of patients hospitalized with pneumonia were influenza positive [16]. In hospital-based 
influenza surveillance of admitted patients with pneumonia in two Thai provinces during 
2005–2008, Simmerman et al. reported that influenza infection was present in 10.4% of 
hospitalized pneumonia patients; of which, 52% were <15 years of age. These authors also 
reported an overall bimodal age distribution for the annual incidence of influenza related 
hospitalized pneumonia, with the highest rates among those <5 and >75 years of age. In a 
prior study conducted in Thailand during 2004–2005, 19.5% of inpatients with pneumonia 
were found to have influenza infection [19]. Similar to our findings on seasonality of 
influenza types and subtypes, Simmerman et al. also noted increases in influenza A 
circulation during the months of the rainy seasons and an additional peak in influenza A 
activity in 2007. In contrast to our study, no apparent seasonality to influenza B virus 
infections were found among hospitalized patients in Thailand [20]. This pattern has been 
consistently reported in Thailand [3,21].
This report is subject to several limitations. Our results may not be generalizable in Vietnam, 
since NISS oversamples certain populations, specifically patients evaluated in the Northern 
Region and most pediatric populations, yet under-samples those <6 months of age and >64 
years of age. For instance, 61% of patients were <15 years of age in NISS, whereas, 
throughout Vietnam only 24% of the entire population are <15 years of age [22]. Also, 
children may be more likely to present for evaluation of ILI than other age groups, though a 
better understanding of the age distribution of ILI in the general population in Vietnam 
would help clarify this issue. Further, our estimation of the percent influenza positive among 
the very young and old age groups may be subject to error, since there were a low number of 
enrollees in these groups. In both groups, patients may be less likely to meet the case 
definition for ILI, since infants and the extremely old may be unable to verbally report 
subjective ILI symptoms, like sore throat. Also, there may be variation in the manner in 
which providers interpreted the survey question on whether a patient was subsequently 
hospitalized and providers may not have had information to accurately determine whether 
each patient was hospitalized. Further, we cannot account for the finding that hospital 
admission among patients presenting with ILI was higher among district than provincial 
hospitals, since provincial hospitals are designed to treat more severe disease. The threshold 
for hospital admission may vary by provider, site and even throughout Vietnam; thus, 
subsequent hospital admission may not be a generalizable measure of severity when 
comparing influenza severity and hospitalization across different settings and countries. 
Furthermore, data on the severity of influenza and detailed information on illness duration, 
use of antiviral medications, and use of extended resources, like mechanical ventilators, to 
manage influenza patients, are not collected by NISS in Vietnam.
In summary, the findings presented in this report have important implications for influenza 
vaccine and health policy in Vietnam and in Southeast Asia. Although year-round circulation 
of influenza viruses occurs in Vietnam, the NISS data suggest that the timing of influenza 
vaccination should consider targeting the prominent mid-year peaks of influenza A viruses 
(Southern Hemisphere vaccine formulation availability). Our findings that influenza virus 
infection represents an important cause of ILI and use of outpatient and inpatient services, 
especially among school-aged children, suggests that a national influenza vaccination 
program targeting school children could be considered [13,23–25]. While ILI is typically a 
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self-limited mild disease, one ILI episode may also be associated with significant financial 
disruption to individuals and families, in terms of missed work or school, in the region [24–
26]. In 2007, a household study conducted in a southern Chinese province estimated that one 
episode of influenza-like illness can result in a 20% loss of individual monthly income [26]. 
Despite the insights that multi-year ILI surveillance has provided, more data on the severity 
of influenza, health services utilization, and further data on the direct and indirect economic 
impact of influenza in Vietnam is warranted, including the collection of additional data on 
the burden of influenza among hospitalized patients with severe acute respiratory infection. 
These additional data will further inform decisions regarding prevention and control of 
influenza in Vietnam and in Southeast Asia.
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Fig. 1. 
Fifteen initial and eleven currently operating sentinel sites, National Influenza Surveillance 
System, January 1, 2006–December 31, 2010.
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Fig. 2. 
Weekly percent of specimens testing positive for influenza by reverse transcription 
polymerase-chain reaction (RT-PCR), by influenza type and subtype—National Influenza 
Surveillance System, Vietnam, January 1, 2006–December 31, 2010. Percent of influenza 
positive specimens by type and subtype has been smoothed for illustrative purposes only in 
this figure. Smoothing was done through local polynomial linear regression of percent 
positive by week (.lpoly bw(1) n(200)).
Nguyen et al. Page 11
Vaccine. Author manuscript; available in PMC 2018 February 20.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Nguyen et al. Page 12
Table 1
Influenza testing results of patients presenting with influenza-like illnessa by gender, region, type of medical 
facility, and age group—National Influenza Surveillance System, Vietnam, January 1, 2006–December 31, 
2010.
No. of presenting with 
ILI tested for influenza
No. of influenza positive 
by RT-PCR (%) No. of hospitalized (%)b
No. of influenza positive by 
RT-PCR of hospitalized (% 
of hospitalized)
Gender
 Female 14,556 3114 (21) 1485 (9.7) 281 (19)
 Male 15,248 3402 (22) 1252 (8.6) 246 (20)
Type of medical facility
 Central hospital 7483 1753 (23) 1375(18) 206 (15)
 Provincial hospital 5020 1009 (20) 55 (1.1) 12 (22)
 District hospital 13,728 3000 (22) 1296 (10) 307 (24)
 Polyclinic 3573 754 (21) 11 (0.3) 2 (18)
Age groups
 0–6 mos. 314 32 (10) 63 (20) 3 (4.8)
 6 mos.–2 years 3610 520 (14) 528(15) 53 (10)
 2–4 years 6212 1247 (20) 646 (10) 108 (17)
 5–14 years 7900 2330 (29) 679 (8.7) 188 (28)
 15–24 years 3684 867 (24) 280 (7.7) 61 (22)
 25–64 years 7195 1404 (20) 479 (6.7) 100 (21)
 >64 years 889 116 (13) 62 (7.0) 14 (23)
Regions
 Northern 12,991 2733 (21) 1560 (12) 350 (22)
 Central 8760 2037 (23) 189 (2.2) 72 (38)
 Southern 8053 1746 (22) 988 (12) 105 (11)
Total 29,804 6516 (22) 2737 (9.3) 527 (19)
a
ILI = influenza-like illness: fever (≥38 °C) with onset of either cough or sore throat ≤3 days prior to presentation.
b
Information on hospitalization was not reported for 219 patients.
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Table 3
Influenza positive RT-PCR testing results by type, region, and overall for patients presenting with influenza-
like illness at any time, during the months of northern hemispherea vaccine formulation availability, and during 
the months of southern hemispherea vaccine availability—National Influenza Surveillance System, Vietnam, 
January 1, 2006–December 31, 2010†.
Region influenza type Influenza positive RT-PCR testing from patients presenting with ILI
Northern hemispherea vaccine 
formulation availability 
(November–April) (% of entire 
year)
Southern hemispherea vaccine 
formulation availability (May–
October) (% of entire year) Entire year (January–December)
Northern region 809 (33) 1664 (67) 2473
A, all seasonal subtypes 347 (21) 1306 (79) 1653
B 462 (56) 358 (44) 820
Central region 811 (47) 1815 (53) 2037
A, all seasonal subtypes 328 (31) 720 (69) 1048
B 483 (70) 203 (30) 686
Southern region 496 (33) 1007 (67) 1503
A, all seasonal subtypes 159 (19) 687 (81) 846
B 337 (51) 320 (49) 657
All regions, A and B 2116 (37) 3594 (63) 5710
A, all seasonal subtypes 834 (24) 2713 (76) 3547
B 1282 (59) 881 (41) 2163
Influenza-like illness, by World Health Organization (WHO): fever (≥38 °C) with either cough or sore throat, and onset of symptoms ≤3 days.
aAs designated by the World Health Organization, based on surveillance of circulating strains in each hemisphere.
†
Testing for influenza was done through polymerase-chain reaction on pharyngeal swabs, excludes those testing positive for 2009 H1N1. Two 
patients had co-infection with seasonal influenza A (H1N1) and B viruses, 12 patients had co-infection with influenza A (H3N2) and B viruses, 
eight were not subtyped, and one had no subtyping information available.
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